Cargando…
Beta-blocker therapy in refractory ascites: A steady march towards the truth
Autores principales: | Bartell, Nicholas, Al-Judaibi, Bandar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9007079/ https://www.ncbi.nlm.nih.gov/pubmed/35295065 http://dx.doi.org/10.4103/sjg.sjg_87_22 |
Ejemplares similares
-
The association between nonselective beta-blockers and portal venous thrombosis in cirrhotic patients: More questions on the horizon
por: Bartell, Nicholas, et al.
Publicado: (2018) -
Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016) -
Correlation Between HBsAg Quantitation and HBV DNA in HBeAg-Negative HBV/D Patients
por: Teriaky, Anouar, et al.
Publicado: (2013) -
Is Vitamin E or Ursodeoxycholic Acid a Valid Treatment Option for Nonalcoholic Fatty Liver Disease in 2016?
por: Beaton, Melanie D., et al.
Publicado: (2016) -
Surgical resection vs radiofrequency ablation in older adults with early stage hepatocellular carcinoma: Where do we stand?
por: Al-Judaibi, Bandar, et al.
Publicado: (2018)